Nephros Inc

Nephros CEO’s 120,000‑share buy and option sell shows a bullish insider confidence, signaling undervaluation and strong upside in the hemodiafiltration market.

Nephros Inc. insider buying spurs confidence: CEO’s 120,000‑share purchase and option hedging hint at future growth, while CFO’s balanced trades confirm leadership buy‑in.